Showing results (151-160 of 243) with videos related to

Sort By:
Pageof 25
European Journal of Gynaecological Oncology|January 1, 1987
Squamous cervical cancer at stage IB and II: a ten years experience, analysis of 231 casesP Benedetti Panici, P F Di Roberto, S Greggi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2009
Discussion about switch strategy in the adjuvant hormonal therapy of breast cancer: psychological aspects of physician-patient communicationA Costantini, A Picardi, M Zilli, et al.
International Journal of Oncology|May 17, 2011
Lack of prognostic value of immunohistochemical determination of epidermal growth-factor receptors in human prostate-cancerC Amatetti, D Angelucci, B Fiorentino, et al.
Journal of Clinical Immunology|May 23, 2000
Elevated plasma levels of 90K (Mac-2 BP) immunostimulatory glycoprotein in HIV-1-infected childrenB Gröschel, J J Braner, M Funk, et al.
Journal of Clinical Pharmacy and Therapeutics|November 25, 2016
A Computer Prescribing Order Entry-Clinical Decision Support system designed for neonatal care: results of the 'preselected prescription' concept at the bedsideB Gouyon, S Iacobelli, E Saliba, et al.
Journal of Biological Regulators and Homeostatic Agents|August 25, 2004
Longitudinal analysis of the 90K glycoprotein in the Italian HIV-seroconversion study: temporal trend and predictability of the maturity of HIV infectionM Dorrucci, S Iacobelli, B Suligoi, et al.
European Journal of Gynaecological Oncology|January 1, 1981
Urinary diversion by ileal conduit in gynecologic oncologyL Villani, F Sacco, P Benedetti Panici, et al.
Cancer Research|August 1, 1995
Suppression of tumor growth in vivo by local and systemic 90K level increaseB Jallal, J Powell, J Zachwieja, et al.
FEBS Letters|March 15, 1993
Purification and characterization of a 90 kDa protein released from human tumors and tumor cell linesS Iacobelli, I Bucci, M D'Egidio, et al.
Biochemical and Biophysical Research Communications|March 17, 1997
Identification of the tumor antigen 90K domains recognized by monoclonal antibodies SP2 and L3 and preparation and characterization of novel anti-90K monoclonal antibodiesN Tinari, M D'Egidio, S Iacobelli, et al.
Pageof 25